4.4 Article

Lifetime Risk and Age at Diagnosis of Symptomatic Knee Osteoarthritis in the US

期刊

ARTHRITIS CARE & RESEARCH
卷 65, 期 5, 页码 703-711

出版社

WILEY
DOI: 10.1002/acr.21898

关键词

-

资金

  1. NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01-AR053112, K24-AR057827, K23-AR054095, P60-AR47782, T32-AR-055885]
  2. VA Connecticut Healthcare System
  3. Centers for Medicare and Medicaid Services, an agency of the US Department of Health and Human Services [HHSM-500-2008-0025I/HHSM-500-T0001]

向作者/读者索取更多资源

Objective To estimate the incidence and lifetime risk of diagnosed symptomatic knee osteoarthritis (OA) and the age at diagnosis of knee OA based on self-reports in the US population. Methods We estimated the incidence of diagnosed symptomatic knee OA in the US by combining data on age-, sex-, and obesity-specific prevalence from the 20072008 National Health Interview Survey, with disease duration estimates derived from the Osteoarthritis Policy (OAPol) Model, a validated computer simulation model of knee OA. We used the OAPol Model to estimate the mean and median ages at diagnosis and lifetime risk. Results The estimated incidence of diagnosed symptomatic knee OA was highest among adults ages 5564 years, ranging from 0.37% per year for nonobese men to 1.02% per year for obese women. The estimated median age at knee OA diagnosis was 55 years. The estimated lifetime risk was 13.83%, ranging from 9.60% for nonobese men to 23.87% in obese women. Approximately 9.29% of the US population is diagnosed with symptomatic knee OA by age 60 years. Conclusion The diagnosis of symptomatic knee OA occurs relatively early in life, suggesting that prevention programs should be offered relatively early in the life course. Further research is needed to understand the future burden of health care utilization resulting from earlier diagnosis of knee OA.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据